Status:
NOT_YET_RECRUITING
Extubation Safety Via Microstream EtCO₂ (IPI) Monitoring
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Hypoxemia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate whether extubation guided by the Integrated Pulmonary Index (IPI)-a composite respiratory score derived from microstream sidestream end-tidal carbon diox...
Detailed Description
The investigators aim to explore the safety of extubation guided by microstream sidestream End-Tidal Carbon Dioxide (EtCO2) monitoring, specifically using the Integrated Pulmonary Index (IPI). End-tid...
Eligibility Criteria
Inclusion
- Patients scheduled for elective abdominal surgery (gastrointestinal surgery in general surgery, gynecology, hepatobiliary surgery, or urology) under general anesthesia with endotracheal intubation in the PACU of the First Medical Center of the PLA General Hospital between April 2025 and April 2026, with ASA classification I-III, aged ≥18 years and \<80 years, and surgical duration ≥1 hour and ≤4 hours.
- Signed informed consent form
Exclusion
- Patients whose endotracheal tube had been removed before entering the PACU.
- Patients with preoperative room-air SpO₂ \< 95%, or those who failed to enter the PACU postoperatively for any reason.
- Patients with a history of sleep apnea.
- Patients undergoing a second surgery within one month.
- Patients with a history of neuromuscular dysfunction.
- Patients with psychiatric or cognitive disorders; a history of abuse of psychotropic or anesthetic drugs; or communication barriers.
- Patients unable to cooperate with the clinical trial.
- The exclusion criteria are as follows:
- Patients with severe arrhythmia after entering the PACU.
- Patients whose extubation is delayed due to medical conditions (e.g., awaiting frozen section results, active bleeding, etc.) after entering the PACU.
- Patients who require a second surgery after extubation in the PACU.-
Key Trial Info
Start Date :
July 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
632 Patients enrolled
Trial Details
Trial ID
NCT06975553
Start Date
July 25 2025
End Date
September 30 2026
Last Update
July 15 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.